The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details

Low Dose Naltrexone (LDN) Provides Surprising Pain Relief

The People's Pharmacy
18 August 2022
https://www.peoplespharmacy.com/articles/low-dose-naltrexone-ldn-provides-surprising-pain-relief

Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

Low-dose naltrexone (LDN) hope for patients with longCOVID syndrome?

MedExpress.pl
07 August 2022
https://www.medexpress.pl/niskodawkowy-naltrexon-ldn-nadzieja-dla-chorych-z-zespolem-longcovid/85098

Asher Goldstein, MD - LDN Radio Show 2022 (LDN; low dose naltrexone)

Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone

J Clin Aesthet Dermatol
November 2020
https://www.academia.edu/79471188/Recalcitrant_Hailey_Hailey_Disease_Successfully_Treated_with_Low_dose_Naltrexone?email_work_card=title

Chronic fatigue: Drug addiction medicine Naltrexone could treat condition

Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for Fibromyalgia

GuruFocus
20 June 2022
https://www.gurufocus.com/news/1770836/scilex-a-sorrento-company-highlights-safety-data-from-phase-1-trial-of-sp104-a-proprietary-low-dose-naltrexone-for-fibromyalgia